CVS vs TER · P/E 16, rev $402.07B vs P/E 76, rev $2.82B
CVS Health Corp (CVS) versus Teradyne Inc (TER) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Teradyne Inc (TER) is a semiconductor equipment & materials company listed on NASDAQ.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported TER revenue for 2024-12-31 was $2.82B. Net income was $542.4M. Revenue was up 5.4% from 2023-12-31 to 2024-12-31. TER currently screens at market cap $63.96B and trailing P/E 75.7.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. TER currently screens at market cap $63.96B and trailing P/E 75.7.
Not investment advice. Open the CVS and TER stock pages for the full models.
Not investment advice.